Product Information

SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.1153 per ML under NDC 50742038642. Its NADAC has been published 77 times since Feb 12, 2025.

FDA first approved this application on Mar 21, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUCRALFATE 1 GM/10 ML SUSP

Sucralfate
$0.1153per ML
Discontinued

Strength

1 g/10mL

NDC

50742038642

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

7/22/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216726

FDA Approved

3/21/2024

TE Code

AB

On Market Since

11/21/2024

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price Statistics

The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 77 times since Feb 12, 2025, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1153 per ML
All-time high$0.2304 (Feb 12, 2025)
All-time low$0.1153 (Jul 22, 2026)
52-week high$0.1253
52-week low$0.1153
Median price$0.1239
Average price$0.1348
Largest weekly change-14.7% (Feb 19, 2025)
Weeks tracked77
Tracking sinceFeb 12, 2025

Price History

1W

N/A

1M

0.0%

3M

-2.2%

6M

-7.0%

1Y

-6.1%

3Y

N/A

5Y

N/A

All

-50.0%

Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Ingenus Pharmaceuticals LLC, is $0.1153 per ML (NDC 50742038642), effective Jul 29, 2026.

How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?

Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 50.0%. It has been tracked across 77 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?

Since Feb 12, 2025, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.2304 (Feb 12, 2025), with a median of $0.1239 per ML.

Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1129 per ML — about 2% below SUCRALFATE 1 GM/10 ML SUSP.

Who manufactures SUCRALFATE 1 GM/10 ML SUSP?

SUCRALFATE 1 GM/10 ML SUSP (NDC 50742038642) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.